Safety of capsule endoscopy using human body communication in patients with cardiac devices

Joo Won Chung, Hye Jin Hwang, Moon Jae Chung, Jeong Youp Park, Hui Nam Pak, Si Young Song

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: The MiroCam (IntroMedic, Ltd., Seoul, Korea) is a small-bowel capsule endoscope that uses human body communication to transmit data. The potential interactions between cardiac devices and the capsule endoscope are causes for concern, but no data are available for this matter. Aim: This clinical study was designed to evaluate the potential influence of the MiroCam capsules on cardiac devices. Methods: Patients with cardiac pacemakers or implantable cardiac defibrillators referred for evaluation of small bowel disease were prospectively enrolled in this study. Before capsule endoscopy, a cardiologist checked baseline electrocardiograms and functions of the cardiac devices. Cardiac rhythms were continuously monitored by 24-h telemetry during capsule endoscopy in the hospital. After completion of procedures, functions of the cardiac devices were checked again for interference. Images from the capsule endoscopy were reviewed and analyzed for technical problems. Results: Six patients, three with pacemakers and three with implantable cardiac defibrillators, were included in the study. We identified no disturbances in the cardiac devices and no arrhythmias detected on telemetry monitoring during capsule endoscopy. No significant changes in the programmed parameters of the cardiac devices were noted after capsule endoscopy. There were no imaging disturbances from the cardiac devices on capsule endoscopy. Conclusions: Capsule endoscopy using human body communication to transmit data was safely performed in patients with cardiac pacemakers or implantable cardiac defibrillators. Images from the capsule endoscopy were not affected by cardiac devices. A further large-scale study is required to confirm the safety of capsule endoscopy with various types of cardiac devices.

Original languageEnglish
Pages (from-to)1719-1723
Number of pages5
JournalDigestive diseases and sciences
Volume57
Issue number6
DOIs
Publication statusPublished - 2012 Jun 1

Fingerprint

Capsule Endoscopy
Human Body
Communication
Safety
Equipment and Supplies
Implantable Defibrillators
Capsule Endoscopes
Telemetry
Korea
Capsules
Cardiac Arrhythmias
Electrocardiography

All Science Journal Classification (ASJC) codes

  • Physiology
  • Gastroenterology

Cite this

Chung, Joo Won ; Hwang, Hye Jin ; Chung, Moon Jae ; Park, Jeong Youp ; Pak, Hui Nam ; Song, Si Young. / Safety of capsule endoscopy using human body communication in patients with cardiac devices. In: Digestive diseases and sciences. 2012 ; Vol. 57, No. 6. pp. 1719-1723.
@article{d501da80f6394b20a273c418f9d468f5,
title = "Safety of capsule endoscopy using human body communication in patients with cardiac devices",
abstract = "Background: The MiroCam (IntroMedic, Ltd., Seoul, Korea) is a small-bowel capsule endoscope that uses human body communication to transmit data. The potential interactions between cardiac devices and the capsule endoscope are causes for concern, but no data are available for this matter. Aim: This clinical study was designed to evaluate the potential influence of the MiroCam capsules on cardiac devices. Methods: Patients with cardiac pacemakers or implantable cardiac defibrillators referred for evaluation of small bowel disease were prospectively enrolled in this study. Before capsule endoscopy, a cardiologist checked baseline electrocardiograms and functions of the cardiac devices. Cardiac rhythms were continuously monitored by 24-h telemetry during capsule endoscopy in the hospital. After completion of procedures, functions of the cardiac devices were checked again for interference. Images from the capsule endoscopy were reviewed and analyzed for technical problems. Results: Six patients, three with pacemakers and three with implantable cardiac defibrillators, were included in the study. We identified no disturbances in the cardiac devices and no arrhythmias detected on telemetry monitoring during capsule endoscopy. No significant changes in the programmed parameters of the cardiac devices were noted after capsule endoscopy. There were no imaging disturbances from the cardiac devices on capsule endoscopy. Conclusions: Capsule endoscopy using human body communication to transmit data was safely performed in patients with cardiac pacemakers or implantable cardiac defibrillators. Images from the capsule endoscopy were not affected by cardiac devices. A further large-scale study is required to confirm the safety of capsule endoscopy with various types of cardiac devices.",
author = "Chung, {Joo Won} and Hwang, {Hye Jin} and Chung, {Moon Jae} and Park, {Jeong Youp} and Pak, {Hui Nam} and Song, {Si Young}",
year = "2012",
month = "6",
day = "1",
doi = "10.1007/s10620-012-2067-x",
language = "English",
volume = "57",
pages = "1719--1723",
journal = "American Journal of Digestive Diseases",
issn = "0002-9211",
publisher = "Springer New York",
number = "6",

}

Safety of capsule endoscopy using human body communication in patients with cardiac devices. / Chung, Joo Won; Hwang, Hye Jin; Chung, Moon Jae; Park, Jeong Youp; Pak, Hui Nam; Song, Si Young.

In: Digestive diseases and sciences, Vol. 57, No. 6, 01.06.2012, p. 1719-1723.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Safety of capsule endoscopy using human body communication in patients with cardiac devices

AU - Chung, Joo Won

AU - Hwang, Hye Jin

AU - Chung, Moon Jae

AU - Park, Jeong Youp

AU - Pak, Hui Nam

AU - Song, Si Young

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Background: The MiroCam (IntroMedic, Ltd., Seoul, Korea) is a small-bowel capsule endoscope that uses human body communication to transmit data. The potential interactions between cardiac devices and the capsule endoscope are causes for concern, but no data are available for this matter. Aim: This clinical study was designed to evaluate the potential influence of the MiroCam capsules on cardiac devices. Methods: Patients with cardiac pacemakers or implantable cardiac defibrillators referred for evaluation of small bowel disease were prospectively enrolled in this study. Before capsule endoscopy, a cardiologist checked baseline electrocardiograms and functions of the cardiac devices. Cardiac rhythms were continuously monitored by 24-h telemetry during capsule endoscopy in the hospital. After completion of procedures, functions of the cardiac devices were checked again for interference. Images from the capsule endoscopy were reviewed and analyzed for technical problems. Results: Six patients, three with pacemakers and three with implantable cardiac defibrillators, were included in the study. We identified no disturbances in the cardiac devices and no arrhythmias detected on telemetry monitoring during capsule endoscopy. No significant changes in the programmed parameters of the cardiac devices were noted after capsule endoscopy. There were no imaging disturbances from the cardiac devices on capsule endoscopy. Conclusions: Capsule endoscopy using human body communication to transmit data was safely performed in patients with cardiac pacemakers or implantable cardiac defibrillators. Images from the capsule endoscopy were not affected by cardiac devices. A further large-scale study is required to confirm the safety of capsule endoscopy with various types of cardiac devices.

AB - Background: The MiroCam (IntroMedic, Ltd., Seoul, Korea) is a small-bowel capsule endoscope that uses human body communication to transmit data. The potential interactions between cardiac devices and the capsule endoscope are causes for concern, but no data are available for this matter. Aim: This clinical study was designed to evaluate the potential influence of the MiroCam capsules on cardiac devices. Methods: Patients with cardiac pacemakers or implantable cardiac defibrillators referred for evaluation of small bowel disease were prospectively enrolled in this study. Before capsule endoscopy, a cardiologist checked baseline electrocardiograms and functions of the cardiac devices. Cardiac rhythms were continuously monitored by 24-h telemetry during capsule endoscopy in the hospital. After completion of procedures, functions of the cardiac devices were checked again for interference. Images from the capsule endoscopy were reviewed and analyzed for technical problems. Results: Six patients, three with pacemakers and three with implantable cardiac defibrillators, were included in the study. We identified no disturbances in the cardiac devices and no arrhythmias detected on telemetry monitoring during capsule endoscopy. No significant changes in the programmed parameters of the cardiac devices were noted after capsule endoscopy. There were no imaging disturbances from the cardiac devices on capsule endoscopy. Conclusions: Capsule endoscopy using human body communication to transmit data was safely performed in patients with cardiac pacemakers or implantable cardiac defibrillators. Images from the capsule endoscopy were not affected by cardiac devices. A further large-scale study is required to confirm the safety of capsule endoscopy with various types of cardiac devices.

UR - http://www.scopus.com/inward/record.url?scp=84864278677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864278677&partnerID=8YFLogxK

U2 - 10.1007/s10620-012-2067-x

DO - 10.1007/s10620-012-2067-x

M3 - Article

C2 - 22311369

AN - SCOPUS:84864278677

VL - 57

SP - 1719

EP - 1723

JO - American Journal of Digestive Diseases

JF - American Journal of Digestive Diseases

SN - 0002-9211

IS - 6

ER -